Groups
Newman J, Thakur N, Peacock T P, Bialy D, Elreafey A M E, Bogaardt C, Horton D L, Ho S, Kankeyan T, Carr C, Hoschler K, Barclay W S, Amirthalingam G, Brown K, Charleston B, Bailey D (2021)
Neutralising antibody activity against SARS-CoV-2 variants, including Omicron, in an elderly cohort vaccinated with BNT162b2
medRxiv
Publisher’s version: https://doi.org/10.1101/2021.12.23.21268293
Berg A, Wright D, Dulal P, Stedman A, Fedosyuk S, Francis M J, Charleston B, Warimwe G M, Douglas A D (2021)
Stability of chimpanzee adenovirus vectored vaccines (ChAdOx1 and ChAdOx2) in liquid and lyophilised formulations
Vaccines 9 (11) , 1249
Publisher’s version: https://doi.org/10.3390/vaccines9111249
Jolles A, Gorsich E, Gubbins S, Beechler B, Buss P, Juleff N, de Klerk-Lorist L-M, Maree F, Perez-Martin E, van Schalkwyk O L, Scott K, Zhang F, Medlock J, Charleston B (2021)
Endemic persistence of a highly contagious pathogen: foot-and-mouth disease in its wildlife host
Science 374 (6563) , 104-109
Publisher’s version: https://doi.org/10.1126/science.abd2475
Jackson B, Harvey Y, Perez-Martin E, Wilsden G, Juleff N, Charleston B, Seago J (2021)
The selection of naturally stable candidate foot-and-mouth disease virus vaccine strains for East Africa
Vaccine 39 (35) , 5015-5024
Publisher’s version: https://doi.org/10.1016/j.vaccine.2021.07.001
Metwally S, Charleston B, Lyons N A (2021)
Foot and Mouth Disease
In: Metwally, S., El Idrissi, A., Viljoen, G. (ed) Veterinary Vaccines: Principles and Applications. Wiley-Blackwell, Hoboken , 205-228
Publisher’s version: https://doi.org/10.1002/9781119506287.ch17
Warimwe G M, Francis M J, Bowden T A, Thumbi S M, Charleston B (2021)
Using cross-species vaccination approaches to counter emerging infectious diseases
Nature Reviews Immunology 21 (12) , 815-822
Publisher’s version: https://doi.org/10.1038/s41577-021-00567-2